National HealthCare: 50% Return In The Past 6 Months And Still Undervalued
National HealthCare: 50% Return In The Past 6 Months And Still Undervalued
National HealthCare Does Not Flinch During Lease Negotiations
National HealthCare Corporation remains a buy despite lease renewal tensions with National Health Investors, as market fears appear overblown. National HealthCare's strong negotiating position, reliable tenant history, and lower patient acuity suggest fair market rent increases will be less than activist claims. A conservative discounted cash flow model shows National HealthCare is undervalued, with 16% upside even after factoring in lease renewal headwinds and a one-time expense.
National HealthCare Is A Buy After Strong First Quarter Results
Strong Earnings Growth Post-Acquisition: NHC reported a 61% year-over-year increase in income from operations and EPS in the two quarters following a Q3 2024 acquisition. Valuation Below Historical Norms: Despite this growth, NHC's share price remains down over 20% in the past six months, with a current P/E ratio of 15.2:well below its historical average. Demographic trends, declining labor costs, and reduced reliance on staffing agencies support future growth. Meanwhile, feared Medicaid cuts now appear unlikely following a recent draft bill.
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of National HealthCare Corporation (NYSE:NHC) and Encourages Investors to Contact the Firm
PHILADELPHIA, PA / ACCESSWIRE / June 11, 2024 / Kaskela Law LLC announces that it is investigating National HealthCare Corporation (NYSE:NHC) ("NHC") on behalf of the company's shareholders. The investigation seeks to determine whether NHC and/or the company's officers and directors violated the securities laws or breached their fiduciary duties to the company's investors in connection with recent corporate actions.
Amalgamated Bank Purchases 3,742 Shares of National HealthCare Co. (NYSEAMERICAN:NHC)
Amalgamated Bank grew its position in National HealthCare Co. (NYSEAMERICAN:NHC – Free Report) by 304.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,972 shares of the company’s stock after acquiring an additional 3,742 shares during the quarter. Amalgamated Bank’s holdings in National HealthCare were worth $460,000 as of its most recent SEC filing. Other hedge funds also recently modified their holdings of the company. Foundry Partners LLC lifted its position in shares of National HealthCare by 44.5% in the 4th quarter. Foundry Partners LLC now owns 56,295 shares of the company’s stock worth $5,203,000 after acquiring an additional 17,345 shares during the period. Brandywine Global Investment Management LLC grew its position in National HealthCare by 25.7% in the third quarter. Brandywine Global Investment Management LLC now owns 45,589 shares of the company’s stock valued at $2,917,000 after acquiring an additional 9,313 shares during the period. Yousif Capital Management LLC acquired a new position in National HealthCare during the fourth quarter worth $621,000. Charles Schwab Investment Management Inc. boosted its stake in shares of National HealthCare by 17.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 174,122 shares of the company’s stock valued at $11,140,000 after purchasing an additional 25,925 shares in the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of National HealthCare by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 1,334,507 shares of the company’s stock worth $85,382,000 after purchasing an additional 4,759 shares during the last quarter. Institutional investors own 56.44% of the company’s stock. National HealthCare Stock Performance National HealthCare stock opened at $100.40 on Monday. National HealthCare Co. has a 1 year low of $56.87 and a 1 year high of $101.81. The stock has a market cap of $1.55 billion, a price-to-earnings ratio of 23.19 and a beta of 0.37. National HealthCare (NYSEAMERICAN:NHC – Get Free Report) last released its earnings results on Friday, February 16th. The company reported $0.98 earnings per share (EPS) for the quarter. The company had revenue of $300.91 million for the quarter. National HealthCare had a net margin of 5.85% and a return on equity of 6.03%. Analyst Upgrades and Downgrades Separately, StockNews.com raised National HealthCare from a “buy” rating to a “strong-buy” rating in a report on Friday, February 9th. Get Our Latest Analysis on National HealthCare About National HealthCare (Free Report) National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities.
